Page 2 - Serum Institute Of India

SII, Bharat Biotech cut Covid vaccine prices for pvt hospitals to Rs 225

SII and Bharat Biotech have been major suppliers of Covid-19 vaccines to the government so far

Don't slack off

Vaccination programme cannot lose govt attention

Low number of Covid cases now as India chose right vaccine: Serum CEO

In India, experts are deciding on mixing vaccines though it is allowed the world over, Poonawalla added

From Coca-Cola to Apple Inc, here are India's best unlisted companies

In all, 18 out of the best 30 unlisted companies in the 2021 league table are local subsidiaries of global multinationals.

NTAGI group to review SII's Covovax data for use in 12 yrs and above

A Covid working group of NTAGI will review this week data of SII anti-coronavirus jab Covovax to decide whether it can be included vaccination programme for inoculating those aged 12 years and above

Serum Institute seeks emergency use authorisation for its tuberculosis vax

The Serum Institute has applied to the Drugs Controller General of India seeking emergency use authorisation for its recombinant BCG (rBCG) vaccine for the prevention of tuberculosis

Second Covishield dose can be given between 8-16 weeks: NTAGI

NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose, official sources said on Sunday

SII seeks inclusion of Covovax in Govt vax drive for 12 yr and above

Registrations for 12-14 year olds on Co-Win will begin from Wednesday

Top Headlines: ex-NSE CEO Chitra arrested; SII bets on non-Covid vaccines

Business Standard brings you the top headlines at this hour.

Malaria to pneumonia vaccines: SII now betting on non-Covid shots

SII has the capacity to produce 250 million monthly doses of Covishield

SII seeks nod for phase-3 of Covid vax Covovax as booster in adults

Serum Institute of India has sought permission from India's drug regulator to conduct a phase-3 study of its COVID-19 vaccine Covovax as a booster dose in adults, official sources said on Sunday.

Serum Institute seeks EUA for its Covovax vaccine for 12-17 yrs age group

Serum Institute of India has sought emergency use authorisation from India's drug regulator for its Covid-19 vaccine Covovax for the 12 to 17 year age group

Serum CEO Adar Poonawalla urges Djokovic to get vaccinated against Covid

Serum Institute of India CEO Adar Poonawalla on Thursday urged Serbian tennis superstar Novak Djokovic to get vaccinated against Coronavirus.

Serum backed Mylab to make and sell Covid-19 vax, working on 2-3 platforms

Partners with Shilpa Medicare to manufacture vaccines, therapeutics

SII urges Mandaviya to reduce gap between 2nd, precaution dose to 3 months

Serum Institute has urged Union Health Minister Mansukh Mandaviya to consider reducing the gap between the second and the precaution dose of Covishield from current nine months to three

No full marketing authorisation yet for Covishield and Covaxin vaccines

Review process to continue, experts studying data submitted

What are the new Covid-19 vaccine platforms?

Rising cases of Covid-19 have unsettled the government. It recently approved two new vaccines. But, what is the difference between these vaccines? What platforms are used to develop them? Find out

'Over 1 bn Covishield doses given in India, abroad testimony of its safety'

100 crore Covishield doses have been given in India and abroad which is a testimony of its safety and efficacy, Serum Institute has informed the DCGI

Serum Institute applies for full marketing authorisation of Covishield

Vaccine accounts for 88 per cent of all the Covid-19 jabs given in India.

Top headlines: GST hike on textiles on hold; full nod sought for Covishield

Business Standard brings you the top headlines on Friday